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Herbalmedicine Semen Persicae is widely used to treat blood stasis inChinesemedicine and other oriental folkmedicines. Although
little is known about the effects of Semen Persicae and its active compounds on neuron differentiation, our pilot study showed that
Semen Persicae extract promoted neurite outgrowth in rat dopaminergic PC12 cells. In the present study, we developed a bioactivity-
guided fractionation procedure for the characterization of the neurotrophic activity of Semen Persicae extract. The resultant
fractions were assayed for neurite outgrowth in PC12 cells based on microscopic assessment. Through liquid-liquid extraction
and reverse phase HPLC separation, a botanical glycoside amygdalin was isolated as the active compound responsible for the
neurotrophic activity of Semen Persicae extract. Moreover, we found that amygdalin rapidly induced the activation of extracellular-
signal-regulated kinase 1/2 (ERK1/2). A specific ERK1/2 inhibitor PD98059 attenuated the stimulatory effect of amygdalin on
neurite outgrowth. Taken together, amygdalin was identified as a potent neurotrophic agent from Semen Persicae extract through
a bioactivity-guided fractional procedure. The neurotrophic activity of amygdalin may be mediated by the activation of ERK1/2
pathway.
1. Introduction
Neurotrophic factors including nerve growth factor (NGF)
and brain-derived neurotrophic factor (BDNF) regulate the
survival, growth, and repair of neurons, thereby maintain-
ing the integrity of neurons [1–3]. Recently, neurotrophic
factors appear to hold great promise in treating not only
acute neuronal injuries due to trauma and stroke, but also
chronic neurodegenerative diseases including Alzheimer’s
disease (AD), Parkinson’s disease (PD), and amyotrophic
lateral sclerosis (ALS) [1, 4, 5]. However, the therapeutic
applications of neurotrophic factors are largely hindered by
the lack of efficient delivery into the brains and the presence of
undesirable side effects [5, 6]. Thus, small molecules capable
of mimicking the actions of these neurotrophic factors may
serve as an alternative therapeutic strategy for neurological
diseases [7]. Rat pheochromocytoma cell line PC12 is widely
used as the cell model for in vitro studies of neuronal differ-
entiation and the underlying mechanisms [8]. For example,
NGF induced the differentiation of PC12 cells into functional
dopaminergic neurons [9]. Mechanistic studies revealed that
NGF induced neurite outgrowth and neuronal differentiation
through sustained activation of extracellular signal-regulated
kinase 1/2 (ERK1/2) by interacting with its specific receptor
tyrosine kinase (TrkA) in PC12 cells [10, 11].
Herbal medicines are used as an enormous source for
drug discovery either as lead compounds or candidate drugs
[12, 13]. Herbal medicine Semen Persicae, the fruit-kernel of
peach, is commonly used to treat blood stagnant syndrome
such as anticoagulant, antiphlogistic, and anodyne in tradi-
tional Chinesemedicine [14, 15]. Interestingly, Semen Persicae
is also used in many herbal medicine formulations including
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Bu-Yang-Huan-Wu-Tang (also designated as ISF-1) for the
treatment of poststroke disorders [16, 17]. However, little is
known about the pharmacological effects of Semen Persicae
on neuronal differentiation.
In the present study, our initial study showed that Semen
Persicae extract promoted neurite outgrowth in PC12 cells.
Thus, we developed a bioactivity-guided fractionation proce-
dure for rapid identification of the neurotrophic agent from
Semen Persicae extract. We also attempted to elucidate the
potential mechanisms underlying the neurotrophic activities
of the active compound derived from Semen Persicae extract.
2. Materials and Methods
2.1. Chemical and Reagents. The dried powder of herbal
medicine Semen Persicae extract was purchased from a local
Pharmaceutical company Nong’s Company (Hong Kong).
Antibodies against ERK1/2, phospho-ERK1/2, 𝛽3-tubulin,
goat anti-rabbit IgG secondary antibody, and Alexa Fluor
594-conjugated goat anti-rabbit IgG antibody were obtained
from Cell Signaling Technology (Boston, MA, USA). Mon-
oclonal antibodies against growth associated protein-43
(GAP-43), microtubule associated protein 2 (MAP2), and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Fluorescein isothiocyanate conjugated phalloidin
(FITC-phalloidin) and other chemicals were obtained from
Sigma-Aldrich Co. (St. Louis, MO, USA) unless indicated
otherwise.
2.2. Cell Culture and Neurite Outgrowth Assay. Rat pheo-
chromocytoma cell line PC12 was obtained from the Amer-
ican Type Cell Culture Collection (Manassas, VA, USA) and
maintained in growth medium (GM) containing Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10%
horse serum (HS), 5% fetal bovine serum (FBS), and 1%
penicillin/streptomycin on collagen I-coated dishes at 37∘C
in a humidified 5% CO
2
atmosphere. Neurite outgrowth
was assayed essentially as described [18]. Briefly, the cells
were seeded in growth medium. After overnight incubation,
the cell culture medium was replaced with differentiation
medium containing 1% HS and 0.5% FBS in DMEM. The
fractions and testing compounds were assayed for neurite
outgrowth. Following 3 days of incubation, the neurite-
bearing cells were examined and the cells bearing neurites
longer than 20𝜇m were enumerated under a phase micro-
scope from Carl Zeiss (Go¨ttingen, Germany).
2.3. High Performance Liquid Chromatography (HPLC) Anal-
ysis. HPLC analysis was performed on a COSMOSIL HILIC
C18 column (250mm × 4.6mm i.d.) under the control of
a Waters HPLC system. This system was equipped with
a Waters 996 Model photodiode array detector (DAD),
a Waters 600S Model system controller, and a gradient
generator. The column was operated in a gradient mobile
phase by mixing an aqueous solution (A) and acetonitrile
(B). The samples were eluted by 5% B for the first 5min,
and followed by a linear gradient from 5% to 95% B over 50
minutes at the flow rate of 1mL/min, and the column was
maintained at room temperature. The elution was monitored
by continuously recording the UV absorbance at 210 nm.
2.4. Bioactivity-Guided Fractionation of Semen Persicae
Extract. Liquid-liquid extraction: twenty grams of the dried
Semen Persicae extract were resuspended in 100mL of Mil-
lipore water and heated at 80∘C for 1 hour. Following the
removal of the insoluble materials by centrifugation, the
supernatant (A) was recovered and sequentially extracted
three times with 100mL of ethyl acetate and n-butanol.
The solvent of each extraction was removed on a Bu¨chi
rotary evaporator under vacuum. The dried residues from
each preparation were dissolved in DMSO and sterilized by
passing through a 0.22𝜇mmembrane filter for the biological
assays.
Semipreparative HPLC separation: For the isolation of
the active compound, the n-butanol fraction was further
separated by semipreparative reverse phase HPLC on an
Alltech Alltima C-18 column (10.0mm I.D. × 250mm, 5 𝜇m).
The column was run in a gradient mobile phase generated
by mixing an aqueous solution (A) and acetonitrile (B). The
samples were eluted by 5% of B for 5 minutes and followed by
a linear gradient elution with up to 95% of B over the period
of 50 minutes. The flow rate was set at 3mL/min and column
temperature was maintained at 25∘C. The UV absorbance
was monitored at the 200 nm to 400 nm wavelengths. A total
of nine fractions were recovered and assayed for neurite
outgrowth in PC12 cells.
2.5. Chemical Identification by Mass Spectrometry (MS). The
HPLC fraction containing the active compoundwas analyzed
by HPLC-MS on a Varian Microsorb C18 column (2 ×
150mm) at the flow rate of 0.8mL/min under the control
of a Waters HPLC system equipped with a 1525 Separations
Module and a Waters 2998 DAD Unit. Mobile phase com-
positions were (A) water with 0.3% (v/v) formic acid and
(B) acetonitrile. Gradient was set as follows: 0–8min, 5–
50% B; 8–10min, 50% B; 10–12min, 50–90% B; 12–15min,
95% B. Flow rate was constant at 0.8mL/min. The column
temperature was maintained at 20∘C. Injection volume was
20𝜇L. The eluents were analyzed on an ABI/Sciex triple
quadrupole mass spectrometer 3200 QTRAP system (Fram-
ingham, MA, USA) equipped with an ESI-Turbo V source
operating in positive ionization mode under the control of
Analyst v1.4.2 data system (Applied Biosystems/MDS Sciex,
Concord, ON, Canada). Mass spectrometry was operated
under the conditions as follows: drying gas N
2
, 10 L/min;
capillary voltage, 20 v; pressure of nebulizer, 30 psi; ion spray
voltage, 4 kV; and capillary temperature, 325∘C.
2.6. Immunocytochemical Staining. At the end of drug treat-
ment, the cells were fixed in 3.7% formaldehyde (PFA),
permeabilized in 0.5% Triton X-100, and blocked in 5%
normal goat serum.The cells were then incubatedwith FITC-
phalloidin and anti-MAP2 antibody overnight at 4∘C, and
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Figure 1: The neurotrophic effect of Semen Persicae extract. (a) Induction of neurite outgrowth by Semen Persicae extract. PC12 cells were
treated with Semen Persicae extract at the concentrations of 0, 0.1, 0.5, 1, and 2mg/mL for 3 days. The cell morphology was examined under
a microscope and representative figures are shown. (b) Quantification of the neurite bearing cells in (a). Data are presented as mean ± SE.
∗
𝑃 < 0.05 Treatment versus Control.
the bound antibodies were detected with an Alexa Fluor 594-
conjugated goat anti-rabbit IgG secondary antibody. The cell
nuclei were visualized by staining with 4󸀠-6-diamidino-2-
phenylindole (DAPI).The fluorescence images were acquired
on a fluorescence microscope from Carl Zeiss (Go¨ttingen,
Germany).
2.7. Western Blotting Analysis. At the end of drug treatment,
the cellular proteins were recovered and analyzed byWestern
blotting as previously described [19]. Briefly, the cellular pro-
teins were resolved by electrophoresis on 10% SDS-PAGE gels
and subsequently transferred onto polyvinylidenedifluoride
(PVDF) membrane. After being blocked with 5% nonfat
milk powder in TBS buffer, the blots were probed with the
antibodies specific for the indicated proteins. The primary
antibodies on the blots were detected with a goat anti-rabbit
IgG-HRP conjugate. The activity of peroxidase was assayed
with enhanced chemiluminescence (ECL) detection reagents
from GE Healthcare (Uppsala, Sweden) according to the
manufacturer’s instruction.
2.8. Statistical Analysis. The results were presented as means
± SD and analyzed by the paired one-tailed 𝑡-test. A 𝑃 value
of <0.05 was considered statistically significant.
3. Results
3.1. Semen Persicae Extract Induces Neurite Outgrowth. The
neurotrophic effect of Semen Persicae extract was evaluated
as previously described [18]. Following the exposure to the
aqueous extract of Semen Persicae at the concentrations
of 0, 0.1, 0.5, 1, and 2mg/mL for 72 hours, the neurite-
bearing cells were examined and enumerated under a micro-
scope. As shown in Figures 1(a) and 1(b), Semen Persicae
extract induced PC12 neurite outgrowth in a concentration-
dependent manner.
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3.2. Bioactivity-Guided Fractionation for the Identification
of the Neurotrophic Agent from Semen Persicae Extract. To
characterize the active compound responsible for promoting
neurite outgrowth, we developed a bioactivity-guided frac-
tionation procedure for the identification of the neurotrophic
agent from Semen Persicae extract (Figure 2(a)).The aqueous
extract of Semen Persicae was sequentially extracted with
ethyl acetate and n-butanol, giving rise to three new fractions,
namely, ethyl acetate extract, n-butanol extract, and H
2
O
phase. All these fractions were evaluated for the promotion
of neurite outgrowth. As shown in Figure 2(b) (upper panel),
n-butanol extract effectively promoted neurite outgrowth.
To characterize the active compound from the n-butanol
extraction, the n-butanol extraction was separated by HPLC
on a C18 column into 9 different fractions based on the pilot
experiment (Figure 2(a)). All these fractions were examined
for the activity of promoting neurite outgrowth in PC12 cells.
As shown in Figure 2(b) (bottom panel), Fraction Number
5 (F5) showed the strongest activity in promoting neurite
outgrowth. The HPLC profile of the n-butanol extraction
was shown in Figure 3(a), whereas F5 exhibited almost a
single peak profile in another HPLC analysis under the
same conditions (Figure 3(b)). Therefore, F5 was directly
characterized by HPLC-MS technology.The positive ESI-MS
𝑚/𝑧 spectrum of F5 showed four major signals including 458
[M + H+], 457 [M], 480 [M + Na+], and 937 [2M + Na+].
The HPLC-MS analysis suggested that F5 could be botanical
glycoside amygdalin (Figure 2(c)). In addition, the ultraviolet
(UV) absorption spectrum (data not shown) suggested that
UV 𝜆max (nm) was corresponding to 200 ± 10 nm. To verify
the chemical identity of F5, we obtained the HPLC profile
for commercial amygdalin (Figure 3(c)). Remarkably, F5 was
eluted in the identical profile as the commercial amygdalin
(Figures 3(b) and 3(c)).
3.3. Amygdalin Induced Neurite Outgrowth in a Concentra-
tion-Dependent Manner. To confirm the possibility of amyg-
dalin as the active compound, we first treated PC12 cells with
commercial amygdalin at the concentrations of 0, 1, 5, 10, and
20𝜇M for 72 hours. The neurite outgrowth was examined
under a microscope. As shown in Figures 4(a) and 4(b),
amygdalin induced neurite outgrowth in a concentration-
dependent manner. Secondly, we examined if amygdalin
could affect the cell viability of PC12 cells. Figure 4(c) clearly
showed that amygdalin would be toxic to the cells at the
concentration up to 20𝜇M.Thirdly, the neuronal biomarkers
𝛽3-tubulin and GAP43 were examined by Western blotting
using specific antibody, whereas GAPDH was also detected
as the control of protein loading. As shown in Figure 4(d),
amygdalin increased the expression of𝛽3-tubulin andGAP43
in a concentration-dependent manner.
3.4. Amygdalin Induced Neurite Outgrowth via Activat-
ing ERK1/2 Pathway. To further investigate the potential
molecular mechanism by which amygdalin induced neurite
outgrowth, we first examined the effect of amygdalin on
the phosphorylation of ERK1/2 in PC12 cell. As shown in
Figure 5(a), amygdalin induced the activation of ERK1/2 in
a time- and concentration-dependent manner. Secondly, we
verified that Semen Persicae extract also induced the activa-
tion of ERK1/2 in a similar fashion,whereas F5 and amygdalin
showed comparable activity in the activation of ERK1/2
(Figure 5(b)). Thirdly, we determined the effect of MEK
inhibitor PD98059 on the activation of ERK1/2 in response
to the treatment of amygdalin and Semen Persicae extract. As
expected, MEK inhibitor PD98059 profoundly inhibited the
activity of amygdalin and Semen Persicae extract on the phos-
phorylation of ERK1/2 (Figure 6(a)). Finally, we explored
the role of ERK1/2 activation in the neurotrophic activity of
amygdalin and Semen Persicae extract. We cotreated the cells
with amygdalin and Semen Persicae extract in the absence or
presence of PD98059, a specific ERK1/2 inhibitor for 3 days.
The cells were stained with FITC-Phalloidin for F-actin, anti-
MAP2 for neuronal characteristics, andDAPI for cell nucleus.
As shown in Figure 6(b), ERK1/2 inhibitor PD98059 almost
abolished the stimulatory effect of amygdalin and Semen
Persicae extract on the expression of neuronal biomarker
MAP2 and the formation of F-actin assembly.
4. Discussion
Herbal medicines are emerging treatments for chronic neu-
rodegenerative diseases [20, 21]. Molecular characterization
of the active compounds from complex herbal medicines
is the key to assess the therapeutic potential of herbal
medicines.We recently attempted to integrate the bioactivity-
guided fractionation method with genome-wide biological
response fingerprinting (BioReF). Compared with the single
target-based bioactivity-guided fractionation, our BioReF-
based strategy guarantees the high success rate for the
identification of the active compounds from complex herbal
medicines. For example, we have successfully identified the
active compounds for inducing heme oxygenase-1 (HO-
1) and leukotriene B4 12-hydroxydehydrogenase (LTB4DH)
from the well-known poststroke rehabilitation formulation
ISF-1 [22, 23]. In the present study, we investigated the activity
of herbal medicine Semen Persicae in promoting neurite
outgrowth in PC12 cells. We developed a bioactivity-guided
fractionation procedure for the identification of amygdalin
as a potent neurotrophic compound from herbal medicine
Semen Persicae.
Therapeutic promotion of adult neurogenesis is crucial
for the treatment of various neurodegenerative diseases [3,
24, 25]. It is well known that NGF regulates the survival and
differentiation of rat dopaminergic PC12 cells [9]. As a result,
this cell line is often used as an important cell model for the
study of neuronal differentiation [26]. The neuronal differ-
entiation of PC12 cells is typically evaluated by enumerating
the neurite-bearing cells or measuring the average neurite
length [18]. In the present study, we investigated the neu-
rotrophic effect of herbal medicine Semen Persicae by robust
examination of the cell morphology under a microscope. In
our pilot study, we treated PC12 cells with Semen Persicae
extract at different concentrations for 3 days. We found
that Semen Persicae extract induced neurite outgrowth in
a concentration-dependent manner. This finding stimulated
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Figure 2: Bioactivity-guided fractionation for the identification of the neurotrophic agent from Semen Persicae extract. (a) Scheme illustrating
the bioactivity-guided fractionation procedure for the isolation of botanical glycoside amygdalin as the neurotropic compound from Semen
Persicae extract. The structure of amygdalin was generated by ChemSketch software (http://www.acdlabs.com). (b, upper panel) Assay of the
fractions generated by liquid-liquid extraction. The aqueous Semen Persicae extract was sequentially extracted by ethyl acetate, n-butanol,
giving rise to three fractions: ethyl acetate extract, n-butanol extract, andH
2
Ophase.These fractions were assayed for the induction of neurite
outgrowth in PC12 cells. The images were acquired under a microscope. (b, lower panel) Assay of the fractions generated by semipreparative
HPLC separation and representative images are shown. The n-butanol extract was separated into a total of 9 fractions by semipreparative
HPLC isolation. All HPLC fractions were assayed for the induction of neurite outgrowth in PC12 cells. The images were acquired under a
microscope and F5 with neurotrophic activities are shown. (c) ESI-MS analysis and chemical information of the active compound. ESI-MS
ions (𝑚/𝑧) were identified by HPLC-MS analysis as described in Section 2.The ultraviolet (UV) absorption spectrumwas recorded by HPLC
UV detector for the identification of UV 𝜆max (nm).
6 BioMed Research International
0.0
1.0
2.0
Ab
so
rb
an
ce
 (a
.u
.)
5 10 15 20 25 30 35 40 45 500
Elution time (min)
(a) Aqueous extract
0.0
0.1
0.2
0.3
Ab
so
rb
an
ce
 (a
.u
.)
5 10 15 20 25 30 35 40 45 500
Elution time (min)
(b) F5 in DMSO
0.0
1.0
2.0
5 10 15 20 25 30 35 40 45 500
Ab
so
rb
an
ce
 (a
.u
.)
Elution time (min)
(c) Amygdalin standard
Figure 3: Representative HPLC chromatographic profiles. (a) HPLC chromatographic profile of n-butanol extract. (b) HPLC chromato-
graphic profile of F5. (c) HPLC chromatographic profile of commercial amygdalin. HPLC chromatographic analyses were performed in a
similar fashion. The HPLC fractions were monitored by recording the UV absorbance at 210 nm.
us to develop a bioactivity-guided fractionation procedure
for rapid identification of the neurotrophic agent from
Semen Persicae extract. Our procedure involved liquid-liquid
extraction and reverse phase HPLC separation (Figure 2(a)).
Firstly, we found that the active compound(s) was mainly
extracted into n-butanol fraction (Figure 2(b)). Subsequently,
n-butanol fraction was separated into a total of nine fractions
by semipreparative RP-HPLC. Based on the assay of neurite
outgrowth, F5 showed strongest activity in promoting neurite
outgrowth (Figure 2(b)). HPLC analysis confirmed that F5
was eluted as a single peak (Figure 3(b)). Thus, we directly
analyzed F5 by HPLC-MS technology on a C18 column. The
𝑚/𝑧 signals (e.g., 458 [M + H+], 457 [M], 480 [M + Na+],
and 937 [2M + Na+]) suggested that the active compound
could be amygdalin. We observed that F5 and amygdalin
were eluted from the column in a highly similar manner.
Importantly, commercial amygdalin not only induced neurite
outgrowth but also increased the expression of multiple
neuronal biomarkers (e.g., 𝛽3-tubulin, GAP43, and MAP-2).
Based on themicroscopic assay of the neurotrophic activity in
Figures 1(b) and 4(b), we could roughly estimate that 1mg/mL
of Semen Persicae extract contains 20 𝜇M of amygdalin.
Amygdalin at the concentrations of 1, 5, 10, and 20𝜇M did
not show any cytotoxicity in PC12 cells. Collectively, we have
successfully isolated botanical glycoside amygdalin as the
active compound responsible for the neurotrophic activity of
Semen Persicae extract.
Amygdalin is a naturally occurring glycoside initially
isolated from the seeds of Prunus dulcis, also known as bitter
almonds as early as 1830 [27]. Amygdalin is also present in
several other related species such as apples, apricots, almonds,
cherries, plums, and peaches [28–30]. Previous studies have
demonstrated that amygdalin exhibited a wide range of
biological activities including anti-inflammatory, anticancer,
antihypertension, and antiatherosclerosis activities [27, 31–
33]. However, the neurotrophic effect of amygdalin has not
been fully investigated. To our knowledge, this study for
the first time demonstrated that amygdalin could effectively
induce neurite outgrowth in an in vitro cellmodel of neuronal
differentiation.
ERK1/2 pathway is an important signaling pathway that
governs cell differentiation, cell survival, and cell cycle
[34, 35]. Previous studies suggested that various natural
compounds such as fisetin, quercetin promoted neurite
outgrowth via the activation of ERK1/2 pathway [36, 37].
In the present study, we found that amygdalin and Semen
Persicae extract induced the phosphorylation of ERK1/2
in a concentration- and time-dependent manner. F5 and
amygdalin showed similar activity to induce the activation
of ERK1/2. Importantly, ERK1/2 specific inhibitor PD98059
almost abolished the effect of amygdalin and Semen Persicae
extract on neurite outgrowth in PC12 cells as evidenced
by staining F-actin with FITC-phalloidin and neuronal
biomarker MAP2 with specific antibody. We also demon-
strated that ERK1/2 specific inhibitor PD98059 profoundly
suppressed the activity of amygdalin and Semen Persicae
extract on the phosphorylation of ERK1/2. These results sug-
gest that amygdalin also induced neurite outgrowth via acti-
vating ERK1/2 pathway. Therefore, the activation of ERK1/2
may be a common mechanism supporting the neurotrophic
activities of a variety of small molecules and neurotrophins.
It is well known that multiple mechanisms could lead to
the activation of ERK1/2. Therefore, future work should be
directed to the elucidation of the exact mechanism by which
amygdalin activates ERK1/2 pathway and the evaluation of
the in vivo neurotrophic activities of amygdalin.
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Figure 4: Evidence for the neurotrophic activity of amygdalin. (a) The neurotrophic activity of amygdalin. PC12 cells were treated with
amygdalin at concentration ranging from 0 to 20 𝜇M for 72 h. The neurite outgrowth was examined under a microscope. The representative
images were shown. (b) Quantitative analysis of amygdalin-induced neurite outgrowth. Data are presented as mean ± SD (𝑛 = 3). ∗𝑃 < 0.05
(Treatment versus Control). (c) Effect of amygdalin on the cell viability. PC12 cells were treated as described in Panels (a) and (b). The cell
viability was determined by standard MTT assay (𝑛 = 3). (d) Effect of amygdalin on the expression of neuronal biomarkers. At the end
of drug treatment, neuronal biomarkers were detected by Western blotting as described in Section 2. Three independent experiments were
performed. The mean values for fold of induction were shown under each treatment.
5. Conclusions
In conclusion, we developed a bioactivity-guided fraction-
ation procedure for rapid identification of amygdalin as
a potent neurotrophic agent from herbal medicine Semen
Persicae. Mechanistic studies revealed that the neurotropic
effect of amygdalin might be mediated by the activation of
ERK1/2 pathway. Thus, amygdalin may serve as a promising
lead candidate for the development of new drugs against
neurodegenerative diseases.
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Figure 5: Activation of ERK1/2 pathway by amygdalin and amygdalin-containing fractions. (a) Effect of amygdalin on the phosphorylation of
ERK1/2. PC12 were treated with 20𝜇Mof amygdalin for indicated times or different concentrations of amygdalin (0–20𝜇M) for 1 hour. Total
and phosphorylated ERK1/2 were detected byWestern blotting analysis. (b) Effect of amygdalin-containing fractions on the phosphorylation
of ERK1/2. For upper panel, PC12 were treated with Semen Persicae extract (1mg/mL) for indicated times. For lower panel, PC12 were treated
with amygdalin (20𝜇M) or F5 (1mg/mL relative to the parent Semen Persicae extract) for 60 minutes. Total and phosphorylated ERK1/2 were
detected by Western blotting analysis. Three independent experiments were performed. The mean values for fold of induction were shown
under each treatment.
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Figure 6: Potential role of ERK1/2 in the neurotrophic activity of amygdalin. (a) Effect ofMEK inhibitor PD98059 on the activation of ERK1/2
by amygdalin and Semen Persicae extract. PC12 were incubated with amygdalin (20𝜇M) or Semen Persicae extract (1mg/mL) at the presence
or absence of PD98059 (20𝜇M) for 60 minutes. Total and phosphorylated ERK1/2 were detected by Western blotting analysis. (b) Effect of
MEK inhibitor PD98059 on the neurotrophic activity of amygdalin and Semen Persicae extract. After 3 days of incubation with amygdalin
(20 𝜇M) or Semen Persicae extract (1mg/mL) at the presence or absence of PD98059 (20𝜇M), the cells were stained with FITC-phalloidin for
F-actin, anti-MAP2 for neuronal characteristics, and DAPI for cell nucleus. The images were acquired under a fluorescence microscope.
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